Literature DB >> 21297256

Age-related macular degeneration (AMD): Alzheimer's disease in the eye?

Kai Kaarniranta1, Antero Salminen, Annakaisa Haapasalo, Hilkka Soininen, Mikko Hiltunen.   

Abstract

Age-related macular degeneration (AMD) is a late-onset, neurodegenerative retinal disease that shares several clinical and pathological features with Alzheimer's disease (AD), including stress stimuli such as oxidative stress and inflammation. In both diseases, the detrimental intra- and extracellular deposits have many similarities. Aging, hypercholesterolaemia, hypertension, obesity, arteriosclerosis, and smoking are risk factors to develop AMD and AD. Cellular aging processes have similar organelle and signaling association in the retina and brain tissues. However, it seems that these diseases have a different genetic background. In this review, differences and similarities of AMD and AD are thoroughly discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21297256     DOI: 10.3233/JAD-2011-101908

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  97 in total

1.  Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

Authors:  Walter J Lukiw; Bhattacharjee Surjyadipta; Prerna Dua; Peter N Alexandrov
Journal:  Int J Biochem Mol Biol       Date:  2012-03-20

2.  Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.

Authors:  Vera L Bonilha; Brent A Bell; Mary E Rayborn; Ivy S Samuels; Anna King; Joe G Hollyfield; Chengsong Xie; Huaibin Cai
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

3.  Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina.

Authors:  Junjun Chen; Irina A Pikuleva; Illarion V Turko
Journal:  Anal Biochem       Date:  2013-08-13       Impact factor: 3.365

4.  Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

Authors:  Marta Cosín-Tomás; Anna Antonell; Albert Lladó; Daniel Alcolea; Juan Fortea; Mario Ezquerra; Albert Lleó; Maria José Martí; Mercè Pallàs; Raquel Sanchez-Valle; José Luís Molinuevo; Coral Sanfeliu; Perla Kaliman
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

5.  Evaluation of Congo Red Staining in Degenerating Porcine Photoreceptors In Vitro: Protective Effects by Structural and Trophic Support.

Authors:  Camilla Mohlin; Dick Delbro; Anders Kvanta; Kjell Johansson
Journal:  J Histochem Cytochem       Date:  2018-04-06       Impact factor: 2.479

6.  Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

Authors:  Lajos Csincsik; Thomas J MacGillivray; Erin Flynn; Enrico Pellegrini; Giorgos Papanastasiou; Neda Barzegar-Befroei; Adrienne Csutak; Alan C Bird; Craig W Ritchie; Tunde Peto; Imre Lengyel
Journal:  Ophthalmic Res       Date:  2018-04-05       Impact factor: 2.892

7.  Treatment of Stargardt disease with dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-10-12

8.  Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.

Authors:  Kunal Thaker; Marilyn Chwa; Shari R Atilano; Pinar Coskun; Javier Cáceres-Del-Carpio; Nitin Udar; David S Boyer; S Michal Jazwinski; Michael V Miceli; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Neurobiol Dis       Date:  2016-04-22       Impact factor: 5.996

Review 9.  Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.

Authors:  Natalia A Stefanova; Oyuna S Kozhevnikova; Anton O Vitovtov; Kseniya Yi Maksimova; Sergey V Logvinov; Ekaterina A Rudnitskaya; Elena E Korbolina; Natalia A Muraleva; Nataliya G Kolosova
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

10.  The mitochondria-targeted antioxidant SkQ1 restores αB-crystallin expression and protects against AMD-like retinopathy in OXYS rats.

Authors:  Natalia A Muraleva; Oyuna S Kozhevnikova; Anna A Zhdankina; Natalia A Stefanova; Tatyana V Karamysheva; Anzhella Z Fursova; Nataliya G Kolosova
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.